ANI PHARMACEUTICALS INC — Director's Dealing 2017

Apr 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2017-03-31

Reporting Person: PRZYBYL ARTHUR (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-07	Common Stock	G	560	—	Disposed	191246	Direct
2017-03-07	Common Stock	G	560	—	Disposed	190686	Direct
2017-03-31	Common Stock	A	23750	—	Acquired	214436	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-31	Stock Options	$49.51	A	47500	Acquired	2027-03-30	Common Stock (47500)	Direct

Footnotes

F1: The restricted stock and the stock options vests in equal annual installments on the first, second, third and fourth anniversaries of the grant date.